Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trial results with MPA/E2C.

L P Shulman1

  • 1Department of Obstetrics and Gynecology, University of Illinois at Chicago 60612-7313, USA. shulman@uic.edu

The Journal of Reproductive Medicine
|November 15, 2000
PubMed
Summary

A new monthly injectable contraceptive is highly effective and well tolerated, offering infrequent dosing and rapid reversibility. This novel method expands options for preventing pregnancy, with efficacy comparable to sterilization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2017
Same author

Contraception for the perimenopausal woman.

Climacteric : the journal of the International Menopause Society·2016
Same author

Pharmacokinetics of 23-epi-26-deoxyactein in women after oral administration of a standardized extract of black cohosh.

Clinical pharmacology and therapeutics·2009
Same author

Androgens and menopause.

Minerva ginecologica·2009
Same author

Alternatives to oral regimens of contraception.

Minerva ginecologica·2007
Same author

[Late first-trimester invasive prenatal diagnosis--secondary publication. An international randomized trial].

Ugeskrift for laeger·2005

Area of Science:

  • Reproductive Health
  • Clinical Trials
  • Pharmacology

Background:

  • Contraceptive options are continually evolving.
  • New formulations aim to improve efficacy, tolerability, and user convenience.
  • Existing methods have varying adherence rates and side effect profiles.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of a new monthly combination injectable contraceptive in a U.S. population.
  • To compare findings with international studies, including those by the World Health Organization (WHO).
  • To assess the potential of this new method to broaden contraceptive choices.

Main Methods:

  • A multicenter, controlled U.S. trial was conducted.
  • The study evaluated a novel monthly combination injectable formulation.
  • Data on efficacy, tolerability, and user experience were collected.

Main Results:

  • The monthly injectable formulation demonstrated high effectiveness in preventing pregnancy.
  • The formulation was well tolerated by participants.
  • Results align with previous international clinical studies.

Conclusions:

  • The new monthly injectable contraceptive is a safe and effective option.
  • Its infrequent dosing and rapid reversibility are significant advantages.
  • This method offers a compelling alternative, potentially rivaling sterilization in efficacy.

Related Experiment Videos